Punee Pitisuttithum

Author PubWeight™ 9.00^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.	Lancet	2009	5.32
2	International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials.	Vaccine	2009	2.19
3	Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon.	J Acquir Immune Defic Syndr	2006	0.86
4	Mother-infant transfer of anti-human papillomavirus (HPV) antibodies following vaccination with the quadrivalent HPV (type 6/11/16/18) virus-like particle vaccine.	Clin Vaccine Immunol	2012	0.80